# A Postmarketing Study of LEQEMBI in United Kingdom (UK) Participants With Alzheimer's Disease (AD)

> clinical trial · VERIFIED · 2026-08-24

Status: NOT_YET_RECRUITING · Sponsor: Eisai Limited · Condition: Alzheimers Disease

- Company: Eisai Limited
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07781345

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.